dj Orthopedics, Inc., (NYSE:DJO) , today announced that it plans to publicly offer 6,000,000 shares of its common stock. It expects that the offering will consist of 2,750,000 shares to be offered by dj Orthopedics and 3,250,000 shares to be offered by certain of its stockholders. The offering will be made pursuant to the Company's effective shelf registration statement previously filed with the Securities and Exchange Commission. Dj Orthopedics further expects that the Company and one of the selling stockholders will grant an over allotment option to the underwriters for the offering of up to 900,000 shares. J.P. Morgan Securities Inc. and Lehman Brothers Inc. will act as joint book-running managers for the proposed offering. Co-managers of the offering are Piper Jaffray & Co., Wachovia Capital Markets, LLC, First Albany Capital Inc. and WR Hambrecht + Co, LLC.
About dj Orthopedics, Inc.
dj Orthopedics is a global medical device company specializing in rehabilitation and regeneration products for the non-operative orthopedic and spine markets. The Company's broad range of over 600 rehabilitation products, including rigid knee braces, soft goods and pain management products, are used to prevent injury, to treat chronic conditions and to aid in recovery after surgery or injury. The Company's regeneration products consist of bone growth stimulation devices that are used to treat nonunion fractures and as an adjunct therapy after spinal fusion surgery.
The Company sells its products in the United States and in more than 30 other countries through networks of agents, distributors and its direct sales force that market its products to orthopedic and spine surgeons, podiatrists, orthopedic and prosthetic centers, third-party distributors, hospitals, surgery centers, physical therapists, athletic trainers and other healthcare professionals.